Stay updated on CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial
Sign up to get notified when there's something new on the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page.

Latest updates to the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange Detected- Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.SummaryDifference10%
- Check19 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedPage version updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.6%
- Check40 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.6%
- Check47 days agoChange DetectedThe web page has added a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.SummaryDifference46%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CSL312 evaluates prevention in Hereditary Angioedema Clinical Trial page.